Hydroxocobalamine Focus Care (Hydroxocobalamin)

Hydroxocobalamin acts as a vitamin B12 replacement in conditions where cobalamin is deficient or required for detoxification.

• Vitamin B12 deficiency: restores normal B12 levels and supports red blood cell formation.
• Cobalamin deficiency anemia: corrects megaloblastic anemia by enabling DNA synthesis in hematopoietic cells.
• Cyanide poisoning: binds cyanide ions to form cyanocobalamin, facilitating rapid detoxification.

• Hydroxocobalamin provides vitamin B12 activity by serving as a cofactor for methionine synthase and methylmalonyl‑CoA mutase, enzymes essential for DNA synthesis, myelin formation, and red blood cell maturation. In cyanide poisoning, the molecule binds cyanide to create cyanocobalamin, which is then safely excreted, thereby neutralizing the toxin.

Adverse reactions may occur following intramuscular administration of hydroxocobalamin.

Common Side Effects

• Injection site pain: mild to moderate discomfort at the injection site.
• Headache: transient headache occurring within hours.
• Nausea: occasional mild nausea.
• Flushing: temporary skin reddening.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Severe hypotension: marked drop in blood pressure post‑injection.
• Stevens‑Johnson syndrome: rare severe skin reaction.
• Hemolytic anemia: uncommon destruction of red blood cells.
• Severe allergic reaction: includes angioedema or bronchospasm.

Before prescribing hydroxocobalamin, clinicians should consider several safety measures.

• Allergy assessment: verify no known hypersensitivity to cobalamin or formulation excipients.
• Renal impairment: monitor renal function, as the drug is primarily renally excreted.
• Pregnancy: use only if potential benefits justify potential risks, given limited data.
• Concurrent cyanide exposure: evaluate need for adjusted dosing in acute poisoning scenarios.
• Storage at room temperature (below 25°C): keep in the original container, protect from moisture and light.

Hydroxocobalamin may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Nitrous oxide anesthesia: can precipitate severe B12 deficiency; avoid concurrent use.
• Chloramphenicol: may interfere with hematopoiesis, increasing anemia risk.
• High‑dose vitamin C: may reduce hydroxocobalamin’s ability to bind cyanide.

Moderate Interactions (Monitor Closely)

• Metformin: may lower systemic B12 levels; monitor patient status.
• Proton pump inhibitors: can affect overall B12 status; consider periodic assessment.
• Oral folic acid: may mask hematologic signs of B12 deficiency; monitor clinical response.